{"schema_version":"secwatch.filing_event.v1","accession":"0000875045-23-000024","form_type":"8-K","ticker":"BIIB","cik":"0000875045","company_name":"BIOGEN INC.","filed_at":"2023-06-29T23:59:59+00:00","discovered_at":"2026-05-14T18:03:42.513057+00:00","generated_at":"2026-06-13T15:13:08.433710+00:00","sec_items":["5.07","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Biogen shareholders elect directors, ratify auditor, approve say-on-pay at 2023 annual meeting","bullets":["Seven incumbent directors re-elected; Susan K. Langer elected with 64M for, 46.6M against, 8.5M abstentions.","Ratification of PricewaterhouseCoopers as independent auditor for FY2023 approved with 123.4M for, 4.3M against.","Advisory vote on executive compensation approved with 82.6M for, 36.3M against.","Advisory frequency vote set at every one year with 115.8M votes for 1-year.","Broker non-votes of 8.7M shares reported on director elections and compensation items."],"urls":{"canonical":"https://secwatch.observer/filing/0000875045-23-000024","json":"https://secwatch.observer/filing/0000875045-23-000024.json","markdown":"https://secwatch.observer/filing/0000875045-23-000024.md","text":"https://secwatch.observer/filing/0000875045-23-000024.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/875045/000087504523000024/0000875045-23-000024-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/875045/000087504523000024/biib-20230626.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T15:13:08.433710+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"369edb3f83d62dc4906e635e3e6cd93aad271ad8","claim":"BIOGEN INC. shareholders approved Advisory vote on executive compensation at the 2023-06-26 meeting.","evidence_excerpt":"3. Stockholders approved the advisory vote on executive compensation, with the votes cast as follows: Votes For Votes Against Abstentions Broker Non-Votes 82,640,454 36,292,390 191,733 8,719,273","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/875045/000087504523000024/0000875045-23-000024-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-26"}],"fact_type":"shareholder_vote"},{"claim_id":"4d0c3f766a712f62b361e0c4f5a6ef83581f1ac0","claim":"BIOGEN INC. shareholders approved Ratification of selection of PricewaterhouseCoopers LLP as independent registered public accounting firm for fiscal year 2023 at the 2023-06-26 meeting.","evidence_excerpt":"2. Stockholders ratified the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2023, with the votes cast as follows: Votes For Votes Against Abstentions Broker Non-Votes 123,393,644 4,311,034 139,172 —","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/875045/000087504523000024/0000875045-23-000024-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-26"}],"fact_type":"shareholder_vote"},{"claim_id":"e17693959080129b86cc023908793703c31d3e79","claim":"BIOGEN INC. shareholders approved Election of Susan K. Langer to the Board of Directors for a one-year term at the 2023-06-26 meeting.","evidence_excerpt":"5. Stockholders elected Susan K. Langer to the Board of Directors to serve for a one-year term extending until the 2024 annual meeting of stockholders and her successor is duly elected and qualified, with the votes cast as follows: Votes For Votes Against Abstentions Broker Non-Votes 64,037,638 46,616,578 8,470,361 8,719,273","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/875045/000087504523000024/0000875045-23-000024-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-26"}],"fact_type":"shareholder_vote"},{"claim_id":"f4bca95d6aced77ecf850fdb78bc1931d8d906a6","claim":"BIOGEN INC. shareholders approved Election of seven nominees to the Board of Directors for a one-year term at the 2023-06-26 meeting.","evidence_excerpt":"1. Stockholders elected seven nominees to the Board of Directors to serve for a one-year term extending until the 2024 annual meeting of stockholders and their successors are duly elected and qualified, with the votes cast as follows: Nominee Votes For Votes Against Abstentions Broker Non-Votes Caroline Dorsa 91,426,287 27,419,853 278,437 8,719,273 Maria C. Freire 75,764,531 43,230,969 129,077 8,719,273 William A. Hawkins 73,182,735 45,804,008 137,834 8,719,273 Jesus B. Mantas 92,085,202 26,910,381 128,994 8,719,273 Eric K. Rowinsky 68,024,971 50,987,191 112,415 8,719,273 Stephen A. Sherwin 93,133,091 25,889,684 101,802 8,719,273 Christopher A. Viehbacher 116,996,008 2,026,614 101,955 8,719,273","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/875045/000087504523000024/0000875045-23-000024-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-26"}],"fact_type":"shareholder_vote"},{"claim_id":"f7f923986c779c641fa6a1a828ec7a7e7aac36a6","claim":"BIOGEN INC. shareholders approved Advisory vote on frequency of future advisory votes on executive compensation at the 2023-06-26 meeting.","evidence_excerpt":"4. Stockholders approved, on an advisory basis, annually as the frequency of the advisory vote on executive compensation, with the votes cast as follows: 1 Year 2 Years 3 Years Abstentions 115,841,797 75,456 2,254,126 953,198","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/875045/000087504523000024/0000875045-23-000024-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay frequency"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-26"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}